6505--Teriparatide Injection (VA-26-00049896)

Solicitation

This solicitation seeks proposals for the supply of TERIPARATIDE 250MCG/ML (560MCG) INJ, PEN, 2.24ML. The contract will establish national contract prices for products distributed through the VA and DoD Pharmaceutical Prime Vendor (PPV) Programs. The objective is to ensure product availability and consistency nationwide with volume-based, committed-use pricing.

• Product: TERIPARATIDE 250MCG/ML (560MCG) INJ, PEN, 2.24ML.

• Pricing: Offerors must submit prices for the base year and all four option years for Line Item 1. Prices must not exceed two decimal places and must include a 0.50% Cost Recovery Fee.

• Manufacturer Requirements: Offerors not manufacturing the item must submit a Letter of Commitment from the manufacturer. Manufacturers must have acceptable cGMP status with the FDA.

• Product Information: Offerors must provide a unique 11-digit National Drug Code (NDC) for each offered product. Products must be FDA approved and meet cGMP standards.

• Packaging & Labeling: Products must meet specific packaging requirements and include bar code labeling conforming to GS1-128 or HIBCC standards. DSCSA requirements for serialized transaction information and transaction statements must be met.

• Backorders: A backorder occurs if an order is not fulfilled within 15 calendar days. The contractor must inform the Contracting Officer and may propose solutions. Failure to resolve backorders may result in the government buying against the contractor.

• Contract Type: Firm Fixed Price, Indefinite-Delivery Requirements contract.

• Contract Duration: Implementation Period (max 60 days) plus one (1) year Ordering Period with four (4) one (1) year pre-priced option periods.

• Payment Structure: Contractors will receive payments from PPV programs, not directly from the Government. Assignment of payment rights is not permitted.

• Submission Method: Proposals must be submitted via email to billy.fong@va.gov and diana.martinez1@va.gov in Microsoft Word or PDF format, including a scanned copy of the signed SF-1449. Faxed proposals are not acceptable.

• Evaluation: Offers will be evaluated on a Lowest Price Technically Acceptable (LPTA) basis. Technical acceptability includes meeting product descriptions, unique NDC, FDA approval, FDA cGMP compliance, and manufacturing facility clearance.

• Key Deadlines: Offerors must submit proposals by the exact time specified. Specific deadlines for amendments or other submissions will be communicated.

• Subcontracting Plan: Non-small business concerns must submit an approved subcontracting plan for contracts over $900,000.

• SAM Registration: Offerors must maintain current and accurate registration in the System for Award Management (SAM).

• Manufacturer/Distributor: Offerors must indicate if they are the manufacturer or a distributor and provide necessary documentation.

• The solicitation references several attachments (A, B, C, D) for PPV contractor details, estimated requirements, and subcontracting plan templates.

• Offerors must acknowledge any amendments issued.

• The contract will be awarded to one responsible offeror for line-item 1, covering the base year and all option years.

Solicitation / RFP / RFQ

This is a pre-solicitation notice for an unrestricted procurement of Teriparatide Injection. The Department of Veterans Affairs (VA) National Acquisition Center intends to issue a Request for Proposal (RFP) for an uninterrupted supply of this medication for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS).

• Supply of Teriparatide Injection.

• Offerors must state the exact name (as it appears on the label) by which the drug will be supplied.

• Offerors must have an NDC number unique to them for the drug.

• The contract items will be distributed through the VA’s and DOD’s respective Pharmaceutical Prime Vendor Programs.

• The contract period will be for one year with four pre-priced one-year option periods.

• The solicitation (RFP # 36E79726R0020) will be issued electronically in commercial item format in accordance with FAR Part 12.

• Tentative closing date for proposals is May 19, 2026.

• All responsible sources may submit an offer that will be considered if timely received.

• This procurement is unrestricted.

• Estimated annual requirements include 39,038 units of TERIPARATIDE 250MCG/ML (560MCG) INJ, PEN, 2.24ML.

• No paper copies of the solicitation will be available; interested offerors must check https://sam.gov/ for electronic issuance and any future amendments.

• The NAICS code for this procurement is 325412.

• Point of Contact: Billy Fong, Contract Specialist, billy.fong@va.gov, 708-786-4992.